Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.75−0.18 (-0.64%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
Zenas BioPharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Zenas BioPharma's operating cash flow for the twelve months ending Sep 30, 2026 was -$242.83M. For fiscal 2025 it was -$172.33M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$172.33M | – |
| FY2024 | Dec 31, 2024 | -$119.67M | – |
| FY2023 | Dec 31, 2023 | -$30.53M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$57.98M | – |
| Q2 FY2026 | Jun 30, 2026 | -$57.24M | – |
| Q1 FY2026 | Mar 31, 2026 | -$75.20M | – |
| Q4 FY2025 | Dec 31, 2025 | -$52.41M | – |
| Q3 FY2025 | Sep 30, 2025 | -$41.13M | – |
| Q2 FY2025 | Jun 30, 2025 | -$41.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$37.05M | – |
| Q4 FY2024 | Dec 31, 2024 | -$38.55M | – |
| Q3 FY2024 | Sep 30, 2024 | -$31.06M | – |
| Q2 FY2024 | Jun 30, 2024 | -$30.96M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.10M | – |
| Q4 FY2023 | Dec 31, 2023 | -$15.40M | – |
See a number that looks wrong?